Pterostilbene.

Pterostilbene engages the sirtuin enzymes that regulate cellular energy and repair signaling, and those enzymes consume NAD+ as their cofactor. Nicotinamide riboside is a direct NAD+ precursor, so it supplies the coenzyme the sirtuin pathway draws on, which is why the two are commonly formulated together.

NMN raises the cell's NAD+ pool through the salvage route, and NAD+ is the required cofactor for the sirtuin enzymes pterostilbene helps activate. Pairing a precursor that builds the coenzyme with a compound that stimulates the enzymes that spend it keeps the pathway supplied on both ends.

Both are stilbene polyphenols that engage overlapping antioxidant and sirtuin signaling pathways. Pterostilbene carries two methyl groups where resveratrol does not, giving it greater metabolic stability and absorption, so the pair covers similar biochemistry with differing persistence in the body.

Quercetin occupies the sulfotransferase and UGT capacity that would otherwise conjugate stilbenes, so co-dosing slows pterostilbene clearance and raises circulating exposure. This is the same competition for conjugation seen across the polyphenol class.

Piperine inhibits intestinal glucuronidation and efflux, the two routes that limit stilbene bioavailability. Adding it raises how much intact pterostilbene reaches circulation.

The sirtuin deacetylases pterostilbene is used to nudge consume NAD as a cosubstrate for every reaction cycle. Without adequate NAD the enzyme has no fuel, which is why the two are formulated together.

Urolithin A drives mitophagy, the removal of worn mitochondria, while pterostilbene pushes on biogenesis signalling through PGC-1alpha. Clearance and renewal are two halves of one turnover cycle.

New mitochondria built under PGC-1alpha signalling need electron carriers to run, and CoQ10 is the mobile carrier in that chain. The pair supplies both the signal and the hardware.

Ascorbate reduces phenolic radicals back to their active form after they quench an oxidant, which applies to stilbenes as it does to other polyphenols. The stilbene pool stays useful for longer.

Both compounds are lipophilic and sit in the lipid phase of membranes, where tocopherol quenches chain-propagating lipid radicals and stilbene phenols can regenerate the tocopheroxyl radical back to tocopherol. Animal feeding work with pterostilbene reports lower malondialdehyde, a lipid peroxidation marker rather than a clinical outcome. The pairing is a formulation convention in antioxidant blends rather than something tested head to head in people.

Dietary pterostilbene in animals is reported to raise glutathione and glutathione peroxidase activity in tissue, which is a marker of antioxidant capacity and not an outcome. The proposed route is Nrf2 signalling, which drives transcription of the enzymes that make and recycle glutathione. Oral glutathione contributes cysteine equivalents to the same pool, so the two act at different points of one system.

N-acetylcysteine delivers cysteine, the rate-limiting substrate for glutathione synthesis. Pterostilbene appears to act upstream on the transcription of glutathione-handling enzymes, so substrate supply and enzyme expression are complementary steps. Neither step compensates for the other when the second is limiting.

Lipoic acid and its reduced form move between the aqueous and lipid phases and can regenerate ascorbate and tocopherol radicals. Pterostilbene works in the same membrane compartment. The combination is mechanistic reasoning about a shared redox network, not a combination that has been measured together in people.

Pterostilbene carries two methoxy groups in place of hydroxyls, which makes it markedly more lipophilic and poorly soluble in water. Dissolving it in a medium-chain triglyceride carrier keeps it in solution through gastric transit and puts it into the mixed micelle phase that fat absorption uses. This is a formulation route, not an effect on the compound itself.

Phospholipid dispersions emulsify poorly soluble polyphenols and hold them in a form the small intestine can take up. Lecithin is used this way across the stilbene and curcuminoid category. The step addresses solubility at the point of absorption and says nothing about what happens after uptake.

Phosphatidylcholine complexes are a standard way of presenting lipophilic plant phenols to the gut wall. The reasoning transfers to pterostilbene from the wider polyphyenol category rather than from stilbene-specific data. Read it as formulation practice.

Catechins and stilbenes converge on the same antioxidant response element signalling and are handled by overlapping conjugation enzymes. The additive part is signalling; the competitive part is metabolism. Both are mechanistic rather than measured for this combination.

Sulforaphane modifies cysteine residues on Keap1 and releases Nrf2, the same transcription factor that stilbenes are described as activating by a different route. Two inputs into one transcriptional programme are usually described as complementary rather than duplicative. This is mechanism, not a clinical result.

Silymarin flavonolignans inhibit UDP-glucuronosyltransferase activity in vitro, and glucuronidation is the main route that clears stilbenes. Co-ingestion could raise the fraction of unconjugated pterostilbene. The interaction is inferred from enzyme work and has not been measured for this pair in people.

Animal feeding studies report that dietary pterostilbene shifts lipid handling and glucose-related markers, and berberine acts on AMPK signalling that touches the same pathways. Both are markers measured in animals, not outcomes in people. Anyone tracking blood sugar with a clinician should say what they are taking.

A long-chain triglyceride matrix supports absorption of a lipophilic stilbene, and animal work reports pterostilbene influencing lipid metabolism markers. Highly unsaturated oils are also the substrate most vulnerable to peroxidation, which is the pool a phenolic antioxidant protects. The pairing is formulation logic supported by animal markers.

Grape seed procyanidins and pterostilbene both come from the grape and berry phenolic family and act on overlapping redox signalling. Blending them broadens the range of phenolic structures present rather than raising the dose of any one. No combination trial defines the pairing.

Work against multidrug-resistant bacteria describes pterostilbene binding iron as part of how it acts, so the molecule has demonstrable iron-chelating behaviour. Applied to a supplement plan, a chelator in the gut lumen at the same time as an iron dose is a reason to space the two rather than combine them. The chelation is documented in a microbiological setting, not in human absorption studies.

Astaxanthin spans the lipid bilayer and quenches radicals at both membrane surfaces, while phenolics such as pterostilbene act at the polar interface. The two occupy different positions in the same membrane. The combination is structural reasoning about antioxidant placement.

Spermidine is described as an autophagy inducer and stilbenes are described as acting through sirtuin and AMPK signalling, which feeds the same process. The overlap is at the level of cell housekeeping pathways. Nothing has measured the pair together in people.